Global in Vitro Diagnostics Market by Latest Trend, Share, Size, Application, Growth and Forecast to 2024
Global In Vitro Diagnostics/IVD Market By Technology (Immunochemistry/Immunoassays, Clinical Chemistry, Molecular Diagnostics, Clinical Microbiology, Hematology, Coagulation and Hemostasis), By Product & Service (Reagents & Kits, Instruments, Data Management Software, Services), By Application (Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing or Pharmacogenomics, HIV/AIDS), By End-User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes), By Geography – Industry Trends and Forecast to 2024.
Pune, India -- (SBWire) -- 02/13/2018 --The Global In Vitro Diagnostics Market accounted to USD 60.22 billion in 2016 growing at a CAGR of 5.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
In vitro diagnostic devices are used to detect any kind of infection and diseases through the specimen from the human body to cure diseases. These IVD products can be instruments, reagents, or any system used for the diagnosis of diseases. The market is raised in back few years as molecular diagnostics in personalized medicine is accepted by patients, increase in incidence of chronic and infectious diseases and increase in geriatric population drive the global IVD market.
Request For Free Sample Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-in-vitro-diagnostics-ivd-market
Major Market Drivers and Restraints:
- Growing acceptance of personalized medicine.
- Rising prevalence of chronic diseases.
- Increasing adoption of point-of-care testing.
- Growth in the number of private diagnostic centers.
- Rising healthcare costs and low budgets.
- Stringent government regulations for the manufacturing of IVD products
- Inadequate reimbursement policies
TABLE OF CONTENTS (TOC):
- Introduction
- Market Segmentation
- Market Overview
- Executive Summary
- Premium Insights
- By Type
- By Application
- By End User
- Geography
- Company Profiles
- Appendix
- About Data Bridge Market Research
Request for Full TOC: http://databridgemarketresearch.com/toc/?dbmr=global-in-vitro-diagnostics-ivd-market
Market Segmentation:
The global in vitro diagnostics market is segmented by technology into immunochemistry/immunoassays, clinical chemistry, molecular diagnostics, clinical microbiology, hematology, coagulation and hemostasis. Immunochemistry/Immunoassay is further segmented into ELISA, radioimmunoassay, rapid tests, western blot and enzyme-linked immunospot assay. ELISA is further sub segmented into chemiluminescence immunoassays, fluorescence immunoassays and colorimetric immunoassays.
- Clinical Chemistry is segmented into basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel and specialty chemical tests. Molecular diagnostics is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, microarray, hybridization and DNA sequencing & next-generation sequencing.
- By Product & Service the market is segmented into reagents & kits, instruments, data management software and services.
- By Application the market is segmented into diabetes, infectious diseases, oncology/cancer, cardiology, nephrology, autoimmune diseases, drug testing or pharmacogenomics and HIV/AIDS.
Access Full Report: http://databridgemarketresearch.com/reports/global-in-vitro-diagnostics-ivd-market/
Competitive Analysis:
The global in vitro diagnostics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global in vitro diagnostics market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in global in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott, Siemens Ltd., Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., BD, Johnson & Johnson Private Limited, Qiagen N.V., Sysmex Corporation, Ortho Clinical Diagnostics, DiaSorin S.p.A., Bayer AG, Toshiba Medical Systems Corporation, bioMérieux SA, Sigma-Aldrich Corp, Verax Biomedical Inc., BG Medicine Inc., Kimberly-Clark Corporation, Luminor Medical Technologies Inc., and Targeted Diagnostics & Therapeutics Inc. among others.
Any difficulty? Feel Free to Inquiry: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-in-vitro-diagnostics-ivd-market
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
Media Relations Contact
Sopan Gedam
Manager
Data Bridge Market Research
888-387-2818
http://databridgemarketresearch.com/reports/global-diagnostic-electrocardiograph-ecg-market/
View this press release online at: http://rwire.com/930793